✦ LIBER ✦

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia

✍ Scribed by Byrne, J L; Stainer, C; Cull, G; Haynes, A P; Bessell, E M; Hale, G; Waldmann, H; Russell, N H

Book ID: 110012400
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 81 KB
Volume: 25
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a graft-versus-leukaemia effect

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

✍ O. Ringdén; M. Labopin; N. C. Gorin; N. Schmitz; U. W. Schaefer; H. G. Prentice; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Effect of graft-versus-host disease on t

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

✍ Kanda, Y; Izutsu, K; Hirai, H; Sakamaki, H; Iseki, T; Kodera, Y; Okamoto, S; Mit 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 533 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets